QA: Serina Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001708599_2019_Serina_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}

Graph

Absolute values for 0001708599, Serina Therapeutics Inc

  xvar xval
0 AssetsCurrent 7,853,000
1 IntangibleAssetsNetIncludingGoodwill 2,709,000
2 PropertyPlantAndEquipmentNet 90,000
3 remainder_Assets 19,000
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,440,000
7 CostOfGoodsAndServicesSold 364,000
8 SellingGeneralAndAdministrativeExpense 5,647,000
9 ResearchAndDevelopmentExpense 5,830,000
10 remainder_Expenses 800,000
11 remainder_Revenues 1,396,000
12 remainder_NetIncome 3,514,000
13 remainder_ComprehensiveNetIncome 15,532,000
  yvar yval
0 Assets 10,671,000
1 Liabilities 2,440,000
2 Expenses 12,641,000
3 Revenues 1,396,000
4 StockholdersEquity 8,231,000
5 NetIncome -7,731,000
6 ComprehensiveNetIncome 35,000
7 BaseVar 23,097,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.74
9 EconomicCapitalRatio 3.52

Edgar->Model Mapping

Feature Distribution